Senior Oncology Late-Stage Clinical Scientist

Pfizer Inc; New York (NY); Hybrid; USD 177,000 - 294,000; Full time

Job summary

Pfizer in New York, NY is seeking a Clinical Development Leader to provide scientific oversight, ensure data integrity, and guide late-stage oncology trials within an integrated development strategy. You will partner with cross-functional teams, author critical documents, lead data review, and support regulatory interactions with a focus on solid tumor/hematology oncology and global regulatory readiness.

This role combines scientific leadership with hands-on trial execution in a hybrid work

Qualifications

• PhD/PharmD or MS/BA with extensive clinical research experience in industry/CRO.
• Experience in oncology, especially late-stage (phase 3) trials and regulatory submissions.
• Leadership experience and ability to manage teams across functions.

Responsibilities

• Clinical development expert for assigned studies and therapeutic areas.
• Partner with clinical operations, safety, biostatistics and regulatory teams.
• Oversee data integrity and quality of clinical trials.
• Represent study team in governance meetings and regulatory submissions.
• Author protocols, ICFs, and contribute to study reports and responses.
• Set data review strategy and monitor emerging safety data.
• Lead cross-functional optimization of development procedures.

Skills

Scientific oversight

Data integrity

Clinical development

Leadership

Regulatory submissions

Communication skills

Problem solving

Cross-functional collaboration

Education

PhD/PharmD in a relevant Science

MS in a relevant Science

BA/BS in a relevant Science

Tools

Microsoft Office

Job description

Pfizer in New York, NY is seeking a Clinical Development Leader to provide scientific oversight, ensure data integrity, and guide late-stage oncology trials within an integrated development strategy. You will partner with cross-functional teams, author critical documents, lead data review, and support regulatory interactions with a focus on solid tumor/hematology oncology and global regulatory readiness.

This role combines scientific leadership with hands-on trial execution in a hybrid work